{"resourceType":"ValueSet","id":"2.16.840.1.113883.3.464.1003.196.11.1025","meta":{"versionId":"15","lastUpdated":"2016-01-29T15:36:00.000-05:00","profile":["http://hl7.org/fhir/StructureDefinition/shareablevalueset","http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"]},"extension":[{"url":"http://hl7.org/fhir/StructureDefinition/valueset-author","valueString":"NCQA PHEMUR Author"},{"url":"http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate","valueDate":"2022-12-15"},{"url":"http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate","valueDate":"2016-01-29"}],"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.11.1025","identifier":[{"system":"urn:ietf:rfc:3986","value":"urn:oid:2.16.840.1.113883.3.464.1003.196.11.1025"}],"version":"20150430","name":"AntibodyInhibitor","title":"Antibody Inhibitor","status":"active","experimental":false,"date":"2015-04-30T01:00:08-04:00","publisher":"NCQA PHEMUR","jurisdiction":[{"coding":[{"system":"urn:iso:std:iso:3166","code":"US"}]}],"purpose":"(Clinical Focus: Under Development),(Data Element Scope: Under Development),(Inclusion Criteria: Under Development),(Exclusion Criteria: Under Development)","compose":{"include":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","concept":[{"code":"403866","display":"omalizumab 125 MG/ML Injectable Solution"}]}]},"expansion":{"identifier":"urn:uuid:7f4053d6-5aa5-438b-a554-2d45baee85b4","timestamp":"2023-12-11T02:29:29-05:00","total":0}}